1: Wirahadikusumah Saleh, University of Uppsala, Sweden. Fermented Foods (1975)

2: Yves Delatte . The uses of lactic acid bacteria in the Fur Industry. International Symposium on the Fur Industry York, UK, (1985)

3: Wirahadikusumah Saleh, University of Uppsala, Sweden. Development of lactic acid bacteria during Early Stages of Fermentation in Fish Silage. (1971)

4: H. Tauson, University of Uppsala, Sweden. Lactic acid bacteria in ration for mink in the lactation period. (1982)

5: Ecole Vétérinaire de Toulouse, France. Experiments on lactic acid bacteria on weaning piglets. (1982)

6: T. Yamaguchi, Y. Kuroda, M. Saito, T. Ebina, F. Hoshino and N. Ishida, Tohoku University School of Medicine, 19/ 01/ 1984. Immune Interferoni Production by TH69, a lyophilized preparation of S.faecalis in murine spleen cultures.

7: D. Iannello, L. Bonina, D. Delfino, M.C. Berlinghieri, M.R. Gismondo and P. Mastroeni, Messina University, Italy. Effect of oral Administration of a variety of bacteria on depressed macrophage functions in tumor-bearing rats. Ann. Immunol. (Inst. Pasteur) 1984. 135 C pp., 345-352

8: Miyoshi Ikawa. Nature of the lipids of some lactic acid bacteria. J. Bacteriology Vol. 85, 1963, pp. 772-781

9: G. H. Spray. Microbiological assay of folic acid activitgy in human serum. Jour. Microbiology, 1953, 17 pp. 660-665

10: G. Weeks & S. Wakil. Studies on the control of fatty acid metabolism. Journal of Biol. Chem. Vol. 245, 8 (1970) April 25, pp. 1913-1921

11: Volker Rusch. Bacteriotherapy with Normal Intestinal S. faecalisvaccine in humans: Results of a double study. Microecology and Therapy. Vol. 15 ,pp. 313-318 (1985)

12: V. Rusch, R.M. Hyde and T.D. Lucckey. Application of S. faecalis and E. coli oral vaccines in humans and animals. Prog. Fd. Nutr. Sci. Vol.7, pp. 39-52 (1983 )

13: Yasuo Kawai. Effect of cellular extracts of Streptococci on hyperlipidemia in rats, rabbits and humans. Microecology and Therapy, Vol. 14, pp. 109-126 (1984)

14: K. Ishihara & Y. Kawai. Hypocholesterolemically active substances of E. faecalis Kawai. Microecology and Therapy Vol. 16, pp. 75-79 (1985)

15: D. Müting, R. Leimbeck, H. Jochen Flasshoff & V. Rusch. Bifidobacterium bifidum administration in humans: a controlled clinical study in liver cirrhosis. Microecology and Therapy Vol. 16, pp. 271-272 (1986)

16: a) D. Müting, R. Leimbeck & H. J. Flasshoff. The effects of fortified viable Bifidobacterium bifidum on intesninal microbial ecology; a controlled clinical study in liver cirrhosis with portal hypertension. Microecology and Therapy Vol.16, pp. 287-295 (1986)

b) C. Del Vecchio-Blanco, G. Ambrogio, D. Mattera & M. Coltorti. Effect of treatment with S. faecium on the blood ammonia curve following protein loading in subjects with hepatic cirrhosis. Institute of Medical Semiotics, University of Naples, Italy (1984)

17: W. Heit, H. Heit & H. Rodt. The role of microflora in allogenic bone marrow transplantation. Microecology and Therapy Vol. 11, pp. 141-147 (1981)

18: N.R. Hall & A.L. Goldstein. Neurotransmitters and the Immune System in Psychoneuroimmunology. Ader R. Ed. Academic Press, NY (1981)

19: I.R. Rowland, P. Grasso. Appl. Microbiol. 29 7 (1975)

20: J.R. Williams, et al Participation of liver fractions and intestinal bacteria in the metabolism of N-hydroxy-N-2-Fluorenylacetamide in the rat. Biochem. Pharmacol. 19 pp.173-188 (1970)

21: L.A. Wheeler, F.B. Soderberg, P. Goldman. Cancer Research 35 2962 (1975)

22: H.H. Balfour Jr. Cytomegalovirus infections of the gastro-intestinal tract. Microecology and Therapy, Vol.15, pp. 55-56 (1985)

23: R.L. Penn, R.D. Maca & R.D. Berg. Leukemia promotes the translocation of indigenous bacteria from the gastro-intestinal tract to the mesenteric lymph node and other organs. Microecology and Therapy, Vol. 15, pp. 85-91 (1985)

24: Edward Balish. Intestinal Flora and Immunity. Microecology and Therapy, Vol. 16, pp. 157-167 (1986)

25: Animal model of Human Disease: Aleutian Disease. American Journal of Pathology, Vol. 71, No. 2, pp. 345-348 (1973)

26: L.E. Perryman, K.L. bamks & T.C. Maguire. Lymphocyte abnomalities dans in Aleutian Disease virus infection of mink. Journal of Immunology, Vol. 115, No. 1, pp. 22-27 (1975)

27: S. Ducluzeau & P. Raibaud. Les interactions bactériennes dans le tube digestif. Rev. sci. tech. Epiz. 1981, 8 (2),pp.291-311

28: Van der Waaij. Antibiotic choice: the importance of colonization resistance. Chichester: research Studies Press 1983

29: C.E. Bayliss, H.K. Bradley, V. Alun Jones, et al. Some aspects of chronic microbial activity in irritable bowel syndrome associate with food intolerance. Ann. 1 st Super Sanita 1986; 22, pp. 959-64

30: D.A. Burks & A.T. Axon. Adhesive Escherichia Coli in inflammatory bowel disease and infective diarrhoea. Br. Med. J. 1988; 297, pp. 102-04

31: R.W. Ebringer, D.R. Cawdwell, P. Cowling, et al. Sequential studies in ankylosing spondylitis. Association of klebsiella pneumoniae, with active disease. Ann. Rheum. Dis. 1979; 37, pp. 145-51

32: J.O. Hunter. Hypothesis: Food allergy – or entero metabolic disorder? Lancet. Vol. 338, August 24^th, 1991, pp.495-496

33: Christina M. Surawicz . Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Bet Practice & Research Clinical Gastroenterology . Vol. 17, No. 5, pp. 775-783, 2003

34: Lynne V. McFarland, PhD; Christina M Surawicz, MD; Richard N. Greenberg, et al. A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination with Standard Antibiotics for Clostridium difficile Disease. JAMA, June 22/29, 1994, Vol. 271, No 24

35: Gary W. Elmer, PhD; Christins M. Surawicz, MD; Lynne V. McFarland,Phd . Biotherapeutic Agents : A Neglected Intestinal and Vaginal Infections. JAMA, March 20, 1996, Vol 275, No 11 pp. 870-876

36: Yvan Vandenplas. Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea.Part I: Bacteria. Clin Microbiol Infect 1999; 5 pp.299-307

37: Yvan Vandenplas . Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea.Part II: Yeasts . Clin Microbiol Infect 1999; 5 pp .389-395

38: S. J. Klebanoff, S. L. Hillier, D.A Eschebach, A. M. Waltersdorph. Control of the Microbial Flora of the Vagina by H₂O₂ –Generating Lactobacilli. The Journal of Infectious Diseases 1999; 164 pp.94-100

39: Anders Hallén, MD, PhD, Connie Jarstrand, MD, PhD, and Calle Påhlson, MSc. Treatment of Bacterical Vaginosis with Lactobacilli . Reprint requests; Anders Hallén, MD, Department of Dermatology and Venereology, University Hospital, Akademiska sjukhuset, S-75185 Uppsala, Sweden. Received for publication November 19, 1990, revised May 28, 1991, and accepted May 31, 1991.

40: Sharon L. Hillier, Marijane A. Krohn, Lorna K. Rabe, et al. The Normal Vaginal Flora, H₂ O₂ –Producing Lactobacilli, and Bacterial Vaginosis in Pregnant Women. Clinical Infectious Diseases 1993; 16(suppl. 4): pp. 273-81

41: Frank A. M. Klaver, Roelof Van Der Meer. The Assumed Assimilation of Cholesterol by Lactobacilli and Bifidobacterium bifidum Is Due to Their Bile Salt-Deconjugating Activity. Applied Environmental Microbiology, Apr. 1993, Vol. 59,No. 4, pp.1120-1124

42: Amal K. Mitra, Golam H. Rabbani . A Double-Blind, Controlled Trial of Bioflorin (Streptococcus faecium SF68) in adults With Acute Diarrhea Due to Vibrio cholerae and Enterotoxigenic Escherichia coli. Gastroentology 1990; 99, pp. 1149-1152

43: E. Camarri, A. Belvisi, G. Guidoni, et al. A Double-Blind Comparison of Two Different Treatments for Acute Enteritis in Adults. Chemotherapy 1981 Vol. 27, pp. 466-470

44: Gaetano Bellomo, Antonio Mangiane, Luigi Nicastro, Giuliano Frigerio. A Controlled Double-Blind study of SF 68 strain as a Biological Preparation for the treatment of Diarrhoea in Pediatrics. Current Therapeutic Research Vol. 28, No. 6, December 1980

45: E. J. Schiffrin, F. Rochat, H. Link-Amster, et al Immunomodulation of Human Blood Cells Following the Ingestion of Lactic Acid Bacteria. 1995 J Dairy Sci 78:491-497

46: Dr. J.N. Kenyon M.D. M.B. Ch.B., Y.G.A. Delatte . The Therapeutic aspects and properties of lactic acid bacteria. November 1991, reviewed Febryary 1992, private communication

47: K.A. van Hoeij- de Boer, J. Schrijver. The Ecology of the Intestine. Nutricia Reasearch Zoetermeer 1991

48: S.C Nannan Panday, E.J. Vollaard. Bacteriotherapy with Lactobacilli. Pharm. Weekbl.1993; 128(28); 807-15

49: Minja Miettinen, Jaana Vuopio-Varkkila, Kari Varkkila. Production of Tumor Necrosis Factor Alpha, Interleukin-6 and Interleukin-10 by Lactic acid Bacteria. Manuscript version 30.10.95 Leiras, Turku

50: M.Borgia, N. Sepe, V. Brancato, R. Borgia. A Controlled Clinical Study on Strepcoccus Faecium Preparation For The Prevention of Side Reactions During Long-Term Antibiotic Treatment . Current therapeutic research February 1982 Vol. 31 No. 2

51: H. Link-Amster, F. Rochat, K.Y.Saudan, et al Modulation of a Specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunology and Medical Microbiology 10 (1994) 55-64

52: F.M. Driessen, R. De Boer. Fermented milks with selected intestinal bacteria: a healthy trend in new products. Neth. Milk Dairy J. 43 (1989) 367-382

53: Hanne Hove, Inge Nordgaard-Andersen, Per BrØbech Mortensen. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose^1-3 . Am J Clin Nutr 1994; 59:74-9

54: Eileen Hilton, MD; Henry D. Isenberg, PhD;phyllis Alperstein,et al. Ingestion of Yogurt Containing Lactobacillicus acidophilus as Prophylaxis for Candidal Vaginitis. Annals of Internal Medicine 1992; 116: 353-357

55: Glenn E. Hatcher, Randall S. Lambrecht. Augmentation of Macrophage Phagocytic Activity by Cell-Free Extracts of Selected Lactic Acid-producing Bacteria. J Dairy Sci 1993; 76: 2485-2492

56: S. E. Gilliand, D. K. Walker. Factors to Consider When Selecting a Culture of Lactobacillus acidophilus as a Dietary Adjunct to Produce a hypocholesterolemic Effect in Humans. J Dairy Sci 1990; 73: 905- 911

57: C: Del Vecchio-Blanco, G. Ambrogio, D. Mattera, et al. Influence du traitment par Streptococcus faecium (S.F. 68) sur la courbe ammoniémique de charge protéique chez sujets atteints de cirrhose hépatique. Méd. Et Hyg. 1981; 39: 2387-2389

58: F.T. Black, P. L. Andersen, J.Ørskov, F. Ørskov, et al. Prophylactic Efficacy of Lactobacilli on Traveler`s Diarrhea.

59: Hyung-Yong Kim, D.V.M.,M.S., Heyong-Suk Bae, D.V.M.,M.S., Young-Jin Baek, Ph.D . In Vivo Antitumor Effects of Lactic Acid Bacteria on sarcoma 180 Mouse Lewis Lung Carcinoma. Journal of Korean Cancer Association 23,2, june 1991

60: Finn Black, Kurt Einarsson, Ann Lidbeck, et al. Effect of Lactic Acid Producing Bacteria on the Human Intestinal Microflora during Ampicillin Treatment. Scand J Infect Dis 23: 247-254 1991

61: Frank A. M. Klaver, Roelof van der Meer . The Assumed Assimilation of Cholesterol by Lactobacilli and Bifidobacterium bifidum Is due to Their Bile Salt-Deconjugating Activity. Applied and Environmental Microbiology,Apr.1993 Vol. 59 No.4, pp. 1120-1124

62: Meei-yn Lin, Dennis Savaiano, Susan Harlander. Influence of nonfermented Dairy Products Containing Bacterial on Lactose Maldigestion in Humans. 1991 J Dairy Sci 74: 87-95

63: Jose M. Saavedra, Nancy A. Baumann, Irene Oung, et al Feeding of Bifidobacterium Bifidum and Streptococcus Thermophilus to Infants in hospital for prevention of diarrhea and shedding of rotavirus. TheLancet October 15, 1994 Vol.344 pp.1046-1049

64: Buts JP, Bernasconi P, Dive C. Stimulation of secretory IgA and secretory component immunoglobulins in small interstine of rats treated with Saccharomyces boulardii. Dig Dis Sci. 1990 Feb; 35(2):251-256

65: Pothoulakis C, Kelly CP, Joshi MA, Gao N, O´Keane CJ, Castagliuolo I, Lamont JT. Saccharomyces boulardii inhibits Clostridium difficile toxin: A binding and enterotoxicity in rat ileum. Gastroenterology. 1993 Apr;104(4): 1108-1115

66: Castagliuolo I, Riegler MF, Valenik L, Lamont JT, pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999 Jan; 67(1): 302-307

67: de Wit MA, Hoogenboom-Verdegaal AM, Goosen ES, Sprenger MJ, Borgdorff MW. A population based longitudinal study on the incidence and disease burden of gastyroenteritis And Campylobacter and Salmonella infection in four regions of the Netherlands. Eur J Epidemiol. 2000; 16(8): 713-718